Bhaskar Chaudhuri
Fundador en ARCUTIS BIOTHERAPEUTICS, INC. .
Fortuna: 8 M $ al 30/04/2024
Cargos activos de Bhaskar Chaudhuri
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2019 | - |
Fundador | 01/06/2016 | - | |
Independent Dir/Board Member | 01/12/2019 | - | |
Presidente | 01/06/2016 | 01/12/2019 | |
TARSUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/12/2019 | - |
Independent Dir/Board Member | 01/12/2019 | - | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Consultor / Asesor | 01/01/2011 | - |
Inversor de Capital Privado | 01/01/2011 | - |
Historial de carrera de Bhaskar Chaudhuri
Antiguos cargos conocidos de Bhaskar Chaudhuri.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TELIGENT | Director/Miembro de la Junta | 01/11/2010 | 21/07/2021 |
Independent Dir/Board Member | 01/11/2010 | 21/07/2021 | |
Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silvergate Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It specializes in reformulating adult drugs and supplies it to the pediatric market. The company was founded by Frank Segrave in 2010 and is headquartered in Greenwood Village, CO. | Director/Miembro de la Junta | - | 12/06/2019 |
CORIUM INTERNATIONAL INC | Director/Miembro de la Junta | 20/10/2011 | 27/11/2018 |
Independent Dir/Board Member | 06/03/2014 | 27/11/2018 | |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Presidente | 01/01/2009 | 01/09/2010 |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Director/Miembro de la Junta | 01/01/2003 | 01/01/2008 |
Director Ejecutivo | 01/01/2002 | 01/01/2008 | |
Presidente | 01/01/2002 | 01/01/2008 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formación de Bhaskar Chaudhuri.
Louisiana State University | Doctorate Degree |
Jadavpur University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 16 |
India | 2 |
Operativa
Director/Board Member | 9 |
Independent Dir/Board Member | 4 |
President | 2 |
Sectorial
Health Technology | 12 |
Consumer Services | 3 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
TARSUS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Penederm, Inc.
Penederm, Inc. Pharmaceuticals: MajorHealth Technology Penederm Incorporated, Foster City, California, develops and commercializes dermatological products and unique topical delivery technologies that enhance delivery of drugs and skin care products. | Health Technology |
VJGJ, Inc.
VJGJ, Inc. Pharmaceuticals: MajorHealth Technology VJGJ, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ. | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Mylan Bertek Pharmaceuticals, Inc.
Mylan Bertek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Mylan Bertek Pharmaceuticals, Inc. is a pharmaceutical company based in Research Triangle Park, NC. The company's focus is not mentioned in the provided metadata, as the description appears to be unrelated and potentially incorrect. | Health Technology |
Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silvergate Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It specializes in reformulating adult drugs and supplies it to the pediatric market. The company was founded by Frank Segrave in 2010 and is headquartered in Greenwood Village, CO. | Health Technology |
Thesan Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Health Technology |
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Technology Services |
- Bolsa de valores
- Insiders
- Bhaskar Chaudhuri
- Experiencia